Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alanine racemase is an enzyme that catalyzes the reversible conversion of L-alanine to D-alanine. D-alanine is a critical component for the biosynthesis of peptidoglycan, which forms the structural framework of bacterial cell walls. The enzyme is found universally in prokaryotes but is absent from higher eukaryotes, making it an attractive target for antimicrobial drug development. It utilizes pyridoxal 5'-phosphate (PLP) as a cofactor. Inhibitors like D-cycloserine block peptidoglycan synthesis by preventing the production of D-alanine, leading to bacterial cell death. Because humans lack this enzyme entirely, selective inhibition offers high therapeutic potential with low host toxicity.
Inhibition of alanine racemase, preventing D-alanine production necessary for peptidoglycan synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alanine racemase.